Celero Systems Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 7

Celero Systems General Information

Description

Developer of an ingestible diagnostic system designed to detect and reverse opioid overdose. The company's product covers a range of technologies, including the ability to monitor physiology from inside the GI tract and respond to the detected physiology to treat a range of medical conditions, enabling healthcare providers to access physiological data that results in improved patient care.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 152 Lincoln Road
  • Suite 5
  • Lincoln, MA 01773
  • United States
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Corporate Office
  • 152 Lincoln Road
  • Suite 5
  • Lincoln, MA 01773
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Celero Systems Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC Completed Clinical Trials - Phase 1
3. Accelerator/Incubator 09-Dec-2022 Completed Clinical Trials - Phase 1
2. Early Stage VC (Series A) 16-Aug-2021 $3.9M $6.9M Completed Clinical Trials - Phase 1
1. Early Stage VC (Series A) 20-Jun-2019 $3M $3M Completed Clinical Trials - Phase 1
To view Celero Systems’s complete valuation and funding history, request access »

Celero Systems Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view Celero Systems’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Celero Systems Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an ingestible diagnostic system designed to detect and reverse opioid overdose. The company's product cover
Diagnostic Equipment
Lincoln, MA
5 As of 2026

San Jose, CA
 

Gaithersburg, MD
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Celero Systems Competitors (2)

One of Celero Systems’s 2 competitors is Rani Therapeutics, a Formerly VC-backed company based in San Jose, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Rani Therapeutics Formerly VC-backed San Jose, CA
Emergent BioSolutions Corporation Gaithersburg, MD
You’re viewing 2 of 2 competitors. Get the full list »

Celero Systems Patents

Celero Systems Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2024137754-A1 Ingestible electronically triggered drug delivery system Inactive 20-Dec-2022
US-20250367418-A1 Gastric residency system for electronic ingestible devices Pending 04-Apr-2022
WO-2023196803-A2 Gastric residency system for electronic ingestible devices Inactive 04-Apr-2022
WO-2023196803-A3 Gastric residency system for electronic ingestible devices Inactive 04-Apr-2022
US-20220313240-A1 Gastrointestinal suture retention system Inactive 01-Apr-2021 A61B17/0469
To view Celero Systems’s complete patent history, request access »

Celero Systems Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Celero Systems Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
PharmStars Accelerator/Incubator
Co-Win Ventures Venture Capital Minority
Foothill Ventures Venture Capital Minority
Innoventures Accelerator/Incubator Minority
K2X Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Celero Systems FAQs

  • When was Celero Systems founded?

    Celero Systems was founded in 2017.

  • Where is Celero Systems headquartered?

    Celero Systems is headquartered in Lincoln, MA.

  • What is the size of Celero Systems?

    Celero Systems has 5 total employees.

  • What industry is Celero Systems in?

    Celero Systems’s primary industry is Diagnostic Equipment.

  • Is Celero Systems a private or public company?

    Celero Systems is a Private company.

  • What is Celero Systems’s current revenue?

    The current revenue for Celero Systems is .

  • How much funding has Celero Systems raised over time?

    Celero Systems has raised $6.9M.

  • Who are Celero Systems’s investors?

    PharmStars, Co-Win Ventures, Foothill Ventures, Innoventures, and K2X are 5 of 7 investors who have invested in Celero Systems.

  • Who are Celero Systems’s competitors?

    Rani Therapeutics and Emergent BioSolutions are competitors of Celero Systems.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process